Accessibility Menu
 
Arrow-Thin-Down
S&P 500
7,165.08
+0.8%
+56.68
Arrow-Thin-Down
DJI
49,230.71
-0.2%
-79.61
Arrow-Thin-Down
NASDAQ
24,836.60
+1.6%
+398.09
Arrow-Thin-Down
Bitcoin
$77,786.00
-0.3%
-$264.72
Arrow-Thin-Down
AAPL
$271.11
-0.8%
-$2.32
Arrow-Thin-Down
AMZN
$263.99
+3.5%
+$8.91
Arrow-Thin-Down
GOOG
$342.32
+1.4%
+$4.57
Arrow-Thin-Down
META
$675.49
+2.5%
+$16.34
Arrow-Thin-Down
MSFT
$424.53
+2.1%
+$8.78
Arrow-Thin-Down
NVDA
$208.24
+4.3%
+$8.60
Arrow-Thin-Down
TSLA
$376.30
+0.7%
+$2.58
Most Active StocksDaily Stock GainersDaily Stock Losers

Why Hims Is a 10x Stock

Disrupting the medical industry has enormous upside.

By Travis Hoium – Jun 26, 2024 at 4:23AM EST

Hims & Hers (HIMS +8.56%) has been on a growth tear as it reaches more customers and customizes offerings in ways traditional pharmacies can't. And those advantages open up an enormous market for the company. In this video, Travis Hoium digs into the competitive advantage and how Hims & Hers keeps growing.

*Stock prices used were end-of-day prices of June 24, 2024. The video was published on June 25, 2024.

Read Next

About the Author

Travis Hoium
Travis Hoium is a contributing Motley Fool stock market analyst covering solar energy, technology, and growth stocks. Before The Motley Fool, Travis was a mechanical engineer at 3M and founded a virtual reality company. He holds a bachelor’s degree in mechanical engineering and a master’s degree in business administration from the University of Minnesota.
TMFFlushDraw
X@travishoium

Travis Hoium has positions in Hims & Hers Health. The Motley Fool has positions in and recommends Target. The Motley Fool has a disclosure policy. Travis Hoium is an affiliate of The Motley Fool and may be compensated for promoting its services. If you choose to subscribe through their link, they will earn some extra money that supports their channel. Their opinions remain their own and are unaffected by The Motley Fool.

Stocks Mentioned

Hims & Hers Health Stock Quote
Hims & Hers Health
NYSE: HIMS
$30.56
(+8.56%)+$2.41
Target Stock Quote
Target
NYSE: TGT
$129.26
(-0.70%)-$0.91

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services